GlassScriptPhysician profile
David I Kaufman
NPI 1467498766
$260.93
in general payments reported to CMS, 2019-2025
9 companies · $36.38 in 2025
The $36.38 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $89.27 · 2021: $13.86 · 2022: $11.95 · 2023: $44.06 · 2024: $65.41 · 2025: $36.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $110.47 | 2020-2023 | Skyclarys |
| Pfizer INC. | $37.61 | 2024-2025 | |
| Acorda Therapeutics, INC | $22.86 | 2023 | Inbrija |
| Catalyst Pharmaceuticals, INC. | $19.02 | 2024 | |
| Amgen INC. | $18.52 | 2025 | Uplizna |
| Avion Pharmaceuticals | $13.86 | 2021 | |
| Celgene Corporation | $13.35 | 2024 | Zeposia |
| Jazz Pharmaceuticals INC. | $13.29 | 2024 | |
| Allergan, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.